Astria Therapeutics, Inc. (ATXS)
NASDAQ: ATXS · Real-Time Price · USD
9.65
+0.31 (3.32%)
Nov 22, 2024, 4:00 PM EST - Market closed
Astria Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Nov '24 Nov 22, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 545 | 279 | 389 | 70 | 43 | 70 | |
| Market Cap Growth | 196.98% | -28.37% | 454.95% | 63.15% | -38.35% | 124.59% | |
| Enterprise Value | 301 | 186 | 370 | 35 | -9 | 30 | |
| Last Close Price | 9.65 | 7.68 | 14.89 | 5.39 | 12.84 | 35.46 | |
| PB Ratio | 2.21 | 1.15 | 1.76 | 0.57 | 1.06 | 1.95 | |
| P/TBV Ratio | 2.52 | 1.89 | 3.12 | 2.71 | 1.06 | 1.95 | |
| Debt / Equity Ratio | 0.02 | 0.00 | 0.00 | 0.00 | 0.03 | 0.06 | |
| Quick Ratio | 21.90 | 21.34 | 24.99 | 24.12 | 7.03 | 7.20 | |
| Current Ratio | 22.38 | 21.73 | 25.13 | 24.42 | 7.25 | 7.74 | |
| Return on Equity (ROE) | -38.03% | -31.40% | -30.18% | -239.19% | -97.66% | -74.42% | |
| Return on Assets (ROA) | -22.72% | -17.47% | -18.67% | -21.69% | -52.44% | -41.83% | |
| Return on Capital (ROIC) | -23.71% | -18.21% | -19.39% | -23.08% | -58.72% | -46.44% | |
| Earnings Yield | -18.37% | -26.15% | -13.32% | -277.96% | -86.78% | -37.71% | |
| FCF Yield | -17.34% | -24.56% | -11.21% | -43.03% | -75.66% | -38.12% | |
| Buyback Yield / Dilution | -97.76% | -106.03% | -63.81% | -191.81% | -63.87% | -121.55% | |
| Total Shareholder Return | -97.76% | -106.03% | -63.81% | -191.81% | -63.87% | -121.55% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.